MOLINA HEALTHCARE, INC. (MOH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 4B 8B 12B Q3 '21: 7B Q4 '21: 7.4B Q1 '22: 7.8B Q2 '22: 8.1B Q3 '22: 7.9B Q4 '22: 8.2B Q1 '23: 8.1B Q2 '23: 8.3B Q3 '23: 8.5B Q4 '23: 9B Q1 '24: 9.9B Q2 '24: 9.9B Q3 '24: 10.3B Q4 '24: 10.5B Q1 '25: 11.1B Q2 '25: 11.4B Q3 '25: 11.5B Q4 '25: 11.4B Q1 '26: 10.8B Q2 '26: 10.9B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 250M 500M 750M Q1 '15: 351M Q2 '15: 389M Q3 '15: 374M Q4 '15: 413M Q1 '16: 420M Q2 '16: 454M Q3 '16: 457M Q4 '16: 354M Q1 '17: 546M Q2 '17: 254M Q3 '17: 564M Q4 '17: 446M Q1 '18: 615M Q2 '18: 673M Q3 '18: 566M Q4 '18: 664M Q1 '19: 581M Q2 '19: 583M Q3 '19: 561M Q4 '19: 578M Q2 '15 Q1 '16 Q4 '16 Q3 '17 Q2 '18 Q1 '19 Q4 '19

Operating Income Quarterly

0 200M 400M 600M Q2 '21: 273M Q3 '21: 221M Q4 '21: 191M Q1 '22: 372M Q2 '22: 361M Q3 '22: 335M Q4 '22: 105M Q1 '23: 455M Q2 '23: 443M Q3 '23: 359M Q4 '23: 316M Q1 '24: 426M Q2 '24: 434M Q3 '24: 467M Q4 '24: 380M Q1 '25: 433M Q2 '25: 373M Q3 '25: 137M Q1 '26: 83M Q2 '26: 145M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Net Income Quarterly

0 150M 300M 450M Q2 '21: 185M Q3 '21: 143M Q4 '21: 103M Q1 '22: 258M Q2 '22: 248M Q3 '22: 230M Q4 '22: 56M Q1 '23: 321M Q2 '23: 309M Q3 '23: 245M Q4 '23: 216M Q1 '24: 301M Q2 '24: 301M Q3 '24: 326M Q4 '24: 251M Q1 '25: 298M Q2 '25: 255M Q3 '25: 79M Q1 '26: 14M Q2 '26: 60M Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26

Cost of Revenue Quarterly

0 3.5B 7B 10.5B Q3 '21: 6B Q4 '21: 6.4B Q1 '22: 6.6B Q2 '22: 6.9B Q3 '22: 6.7B Q4 '22: 7B Q1 '23: 6.9B Q2 '23: 7B Q3 '23: 7.3B Q4 '23: 7.5B Q1 '24: 8.4B Q2 '24: 8.4B Q3 '24: 8.6B Q4 '24: 9B Q1 '25: 9.5B Q2 '25: 9.8B Q3 '25: 10B Q4 '25: 10.1B Q1 '26: 9.3B Q2 '26: 9.4B Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-400M 0 400M 800M 1.2B Q1 '21: 568M Q2 '21: 493M Q3 '21: 461M Q4 '21: 597M Q1 '22: 363M Q2 '22: 368M Q3 '22: 254M Q1 '23: 916M Q2 '23: 487M Q3 '23: 949M Q1 '24: 214M Q2 '24: -219M Q3 '24: 873M Q4 '24: -224M Q1 '25: 190M Q2 '25: -302M Q3 '25: -125M Q4 '25: -298M Q1 '26: 1.1B Q2 '26: -294M Q2 '21 Q1 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-400M 0 400M 800M 1.2B Q1 '21: 552M Q2 '21: 480M Q3 '21: 434M Q4 '21: 576M Q1 '22: 340M Q2 '22: 341M Q3 '22: 223M Q1 '23: 884M Q2 '23: 456M Q3 '23: 923M Q1 '24: 187M Q2 '24: -246M Q3 '24: 838M Q4 '24: -235M Q1 '25: 168M Q2 '25: -344M Q3 '25: -163M Q4 '25: -299M Q1 '26: 1.1B Q2 '26: -324M Q2 '21 Q1 '22 Q1 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q1 '20: 61M Q2 '20: 59.4M Q3 '20: 59.6M Q1 '21: 58.6M Q2 '21: 58.4M Q3 '21: 58.5M Q1 '22: 58.7M Q2 '22: 58.4M Q3 '22: 58.3M Q1 '23: 58M Q2 '23: 57.9M Q3 '23: 58.1M Q1 '24: 58.3M Q2 '24: 58.2M Q3 '24: 57.7M Q1 '25: 54.8M Q2 '25: 53.7M Q3 '25: 52.5M Q1 '26: 51M Q2 '26: 51.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 8.00 16.00 24.00 Q4 '20: 11.25 Q1 '21: 12.22 Q2 '21: 10.73 Q3 '21: 10.09 Q4 '21: 11.25 Q1 '22: 11.75 Q2 '22: 12.84 Q3 '22: 14.33 Q4 '22: 13.56 Q1 '23: 14.69 Q2 '23: 15.79 Q3 '23: 16.05 Q4 '23: 18.77 Q1 '24: 18.42 Q2 '24: 18.24 Q3 '24: 19.68 Q4 '24: 20.44 Q1 '25: 20.72 Q2 '25: 20.30 Q3 '25: 16.16 Q1 '21 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.